We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+19.87%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$118M
AUM Growth
+$17.9M
Cap. Flow
+$6.34M
Cap. Flow %
5.37%
Top 10 Hldgs %
16.29%
Holding
285
New
33
Increased
176
Reduced
36
Closed
26

Top Buys

Rank Stock Value
1
QQQM icon
Invesco NASDAQ 100 ETF
QQQM
+$1.28M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$1.28M
3
HHH icon
Howard Hughes
HHH
+$976K
4
IONQ icon
IonQ
IONQ
+$633K
5
MICC
The Magnum Ice Cream Company N.V.
MICC
+$623K

Top Sells

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$1.41M
2
RPV icon
Invesco S&P 500 Pure Value ETF
RPV
+$1.31M
3
INGM
Ingram Micro Holding
INGM
+$913K
4
EEFT icon
Euronet Worldwide
EEFT
+$548K
5
WSR
Whitestone REIT
WSR
+$460K

Sector Composition

Rank Sector Weight
1 Healthcare 43.59%
2 Miscellaneous 16.64%
3 Technology 10.39%
4 Industrials 9.8%
5 Real Estate 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$187B
$2.58M 2.19%
20,426
+166
+0.8% +$21.9K
VRTX icon
2
Vertex Pharmaceuticals
VRTX
$139B
$2.48M 2.11%
5,002
+71
+1% +$31.5K
INVH icon
3
Invitation Homes
INVH
$17B
$2.21M 1.87%
73,000
– –
AZN icon
4
AstraZeneca
AZN
$250B
$2.16M 1.83%
11,394
+162
+1% +$30.5K
ROIV icon
5
Roivant Sciences
ROIV
$24.9B
$1.71M 1.45%
48,355
+688
+1% +$20.3K
ARGX icon
6
argenx
ARGX
$64.8B
$1.68M 1.42%
1,806
+12
+0.7% +$9.9K
NBIX icon
7
Neurocrine Biosciences
NBIX
$15.9B
$1.64M 1.39%
9,727
+120
+1% +$17.8K
INCY icon
8
Incyte
INCY
$25.9B
$1.64M 1.39%
14,451
+206
+1% +$20.4K
AXSM icon
9
Axsome Therapeutics
AXSM
$10.8B
$1.6M 1.35%
6,531
+93
+1% +$20.2K
APGE icon
10
Apogee Therapeutics
APGE
$1.53M 1.3%
11,533
+164
+1% +$14.8K
EEFT icon
11
Euronet Worldwide
EEFT
$2.78B
$1.46M 1.24%
20,000
-7,855
-28% -$548K
AEVA
12
Aeva Technologies
AEVA
$1.07B
$1.44M 1.22%
50,000
– –
IWD icon
13
iShares Russell 1000 Value ETF
IWD
$84.3B
$1.4M 1.19%
5,771
-6,054
-51% -$1.41M
RPV icon
14
Invesco S&P 500 Pure Value ETF
RPV
$1.76B
$1.38M 1.17%
12,122
-11,760
-49% -$1.31M
QQQ icon
15
Invesco QQQ Trust
QQQ
$488B
$1.37M 1.16%
+1,860
New +$1.28M
QQQM icon
16
Invesco NASDAQ 100 ETF
QQQM
$105B
$1.37M 1.16%
+4,518
New +$1.28M
BFS
17
Saul Centers
BFS
$806M
$1.31M 1.11%
35,000
– –
INSM icon
18
Insmed
INSM
$27.5B
$1.25M 1.06%
11,699
+2,825
+32% +$342K
IONS icon
19
Ionis Pharmaceuticals
IONS
$9.77B
$1.22M 1.04%
15,430
-4,157
-21% -$313K
ASND icon
20
Ascendis Pharma A/S
ASND
$17.6B
$1.22M 1.04%
4,585
+59
+1% +$13.8K
PTGX icon
21
Protagonist Therapeutics
PTGX
$9.43B
$1.12M 0.95%
9,171
+131
+1% +$13.7K
BLDR icon
22
Builders FirstSource
BLDR
$7.1B
$1.12M 0.95%
12,500
+2,500
+25% +$200K
UMAC icon
23
Unusual Machines
UMAC
$1.2B
$1.11M 0.94%
50,000
+15,000
+43% +$278K
HHH icon
24
Howard Hughes
HHH
$3.84B
$1.07M 0.91%
+15,000
New +$976K
SHY icon
25
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
$1.06M 0.9%
12,954
+3,493
+37% +$287K
1
2 3 4 5

Similar funds

CWM
Curtis Wealth Management Henderson, Nevada $118M AUM
MCM
Masterton Capital Management New York $118M AUM 6.83% 1-Year Est. Return
WUW
Wheels Up Wealth Benicia, California $118M AUM
AGAM
AK Global Asset Management Oakland, California $118M AUM
FWWM
Fiscal Wisdom Wealth Management Canton, Connecticut $118M AUM 72.21% 1-Year Est. Return
3FI
3 Factor Indexing Sacramento, California $118M AUM
ERWM
E&R Wealth Management Mount Pleasant, South Carolina $118M AUM
TFA
TrustWell Financial Advisors Jacksonville, Florida $118M AUM

AlphaCentric Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, AlphaCentric Advisors held 285 positions worth $118M, up 18% from $100M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

AlphaCentric Advisors deployed $6.34M of net new capital in Q2 2026, opening 33 new positions and adding to 176 existing holdings. Its largest new stake was Invesco NASDAQ 100 ETF: 4,518 shares worth $1.37M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 43% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $1.41M trimmed.

  • AlphaCentric Advisors's largest Q2 2026 buy was Invesco NASDAQ 100 ETF: 4,518 shares worth $1.37M.
  • AlphaCentric Advisors added most to Synopsys in Q2 2026, an estimated $400K increase.
  • AlphaCentric Advisors's biggest Q2 2026 reduction was iShares Russell 1000 Value ETF, cutting an estimated $1.41M.
  • AlphaCentric Advisors fully exited Whitestone REIT in Q2 2026, selling an estimated $460K.
  • AlphaCentric Advisors's ten largest holdings make up 16% of its $118M portfolio in Q2 2026.
  • AlphaCentric Advisors opened 33 new positions and closed 26 in Q2 2026.
  • AlphaCentric Advisors's portfolio value rose 18% quarter-over-quarter to $118M.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.